Acetylcholinesterase inhibitors and memantine deprescribing guideline

Using the evidence-based deprescribing guideline method established through the Bruyère Research Institute and the Ontario Pharmacy Evidence Network, Dr. Reeve developed an Australian/Canadian focused prescribing guideline for acetylcholinesterase inhibitors and memantine. Next steps include an evaluation of the guideline impact in the Australian context.

Lead: Dr. Emily Reeve

Co-investigators: Dr. Barbara Farrell,

Contact: emily.reeve@sydney.edu.au

Funder (2016-2020): National Health and Medical Research Council – Australian Research Council Dementia Research Fellowship

Publications:

Reeve E, Farrell B, Thompson W, Herrmann N, Sketris I, Magin P, Chenoweth L, Gorman M, Quirke L, Bethune G, Forbes F, Hilmer S. Evidence-based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine. Sydney: University of Sydney. 2018. Available at: http://sydney.edu.au/medicine/cdpc/resources/deprescribing-guidelines.php